JENNIFER CHANDLER: Open Payments
NPI 1902305295 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 11 payments from 10 companies in 2025. Trend: 2023 $598 · 2024 $664 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $196 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $125 |
| Amgen Inc. | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 1 | $109 |
| Madrigal Pharmaceuticals | 1 | $107 |
| KYOWA KIRIN, INC. | 1 | $73 |
| Otsuka America Pharmaceutical, Inc. | 1 | $69 |
| Alexion Pharmaceuticals, Inc. | 1 | $69 |
| Boston Scientific Corporation | 1 | $59 |
| CORDIS US CORP. | 1 | $16 |
Products named: FABRAZYME, JOURNAVX, TEPEZZA, AIRSUPRA, REZDIFFRA, CRYSVITA, REXULTI, ULTOMIRIS.
Industry payments across MI — which companies pay providers there.
